IRUS-ANZ has moved. From January 2022, new monthly statistics will only be added to the IRUS R5 service. This site is archived. All statistics up to December 2021 will remain available on this site.

Item Statistics

Fingolimod after natalizumab and the risk of short-term relapse

RepositoryUniversity of Melbourne [Minerva Access]
URLhttp://hdl.handle.net/11343/57526
Author(s)orcid:0000-0002-3942-4340; orcid:0000-0003-3778-1376; orcid:0000-0002-9029-6663; orcid:0000-0003-2902-5589; orcid:0000-0002-6329-8946; orcid:0000-0003-4323-2453; orcid:0000-0002-0131-623X; orcid:0000-0003-3940-8727; Jokubaitis, VG; Li, V; Kalincik, T; Izq
Item typeArticle
JournalNeurology, Print_ISSN:0028-3878, Online_ISSN:1526-632X
DOIhttps://doi.org/10.1212/WNL.0000000000000283

Sorry - we've not seen any usage for this item in the last six weeks...

Jisc logo Cranfield logo CAVAL logo